We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Enzyme-Loaded Magnetic Nanoparticles Suitable for Therapeutic and Industrial Applications

By LabMedica International staff writers
Posted on 25 Apr 2016
Members of a novel class of nano-sized transport vessels are composed of only two biocompatible components: an enzyme and magnetite nanoparticles.

Magnetically controlled enzymatic nanoparticles have received much attention for both therapeutic and industrial applications. More...
Such materials usually comprise at least four components: the enzyme, magnetic nanoparticles, stabilizing components, and an organic or inorganic (or hybrid) matrix as a carrier. However, such combinations can affect the magnetic response and/or the enzymatic activity, and also face regulatory restrictions that prevent them from being used for intravenous administration.

To overcome these difficulties, investigators at ITMO University (St. Petersburg, Russia) and their colleagues at the Hebrew University of Jerusalem (Israel), and Cyril and Methodius University (Skopje, Macedonia) developed a new class of magnetically controlled nanoparticles made from enzymes that have been entrapped directly within magnetite particles.

These particles were made by adding enzymes directly to a magnetite hydrosol mixture. Magnetite particles surrounded the enzymes, and after drying, formed a firm porous structure from which the enzyme could not escape.

The investigators reported in the March 16, 2016, online edition of the journal Chemistry of Materials that they had used the direct entrapment approach to create a series of magnetic biocomposites with enzymes of therapeutic and industrial interest including carbonic anhydrase, ovalbumin, horseradish peroxidase, acid phosphatase, proteinase, and xylanase.

The activity of the entrapped enzymes was studied at different temperatures and concentrations, and it was found that they showed remarkable thermal stabilization induced by the magnetite matrix. For example, entrapped carbonic anhydrase catalyzed the decomposition of p-nitrophenylacetate at a temperature of 90 degrees Celsius, while the free enzyme completely lost activity and denaturized at 70 degrees Celsius.

"The nanocomposite is absolutely biocompatible and harmless for injection into the human body," said Dr. Andrey Drozdov, a research associate in the international laboratory of solution chemistry of advanced materials and technologies at ITMO University. "Separately, both magnetite and therapeutic enzymes have medical approval for intravenous injection. Therefore, to approve their joint use should not be difficult. The body already knows what to do with these substances and how to incorporate them into the process of metabolism. Using a magnetic field, the particles can be condensed on blood clots; moreover, such systems will work for quite a long time until the enzyme is completely oxidized."

Related Links:
ITMO University
Hebrew University of Jerusalem
Cyril and Methodius University

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
hCG Whole Blood Pregnancy Test
VEDALAB hCG-CHECK-1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.